UTHR
$541.70-5.19%
as of close, Oct 2, 2026
☾ AH $541.70 -5.19%
United Therapeutics CorporationStock · Health CareRussell 1000 0.03%US Stock Market 0.03%Russell 3000 0.03%MSCI World 0.03%MSCI ACWI 0.02%
United Therapeutics Corporation returns by year
As of market close, Oct 2, 2026
United Therapeutics Corporation returns by year (2000–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $487.25 | $541.70 | 0.0% | +11.2% | |
| 2025 | $352.84 | $487.25 | 0.0% | +38.1% | |
| 2024 | $219.89 | $352.84 | 0.0% | +60.5% | |
| 2023 | $278.09 | $219.89 | 0.0% | -20.9% | |
| 2022 | $216.08 | $278.09 | 0.0% | +28.7% | |
| 2021 | $151.79 | $216.08 | 0.0% | +42.4% | |
| 2020 | $88.08 | $151.79 | 0.0% | +72.3% | |
| 2019 | $108.90 | $88.08 | 0.0% | -19.1% | |
| 2018 | $147.95 | $108.90 | 0.0% | -26.4% | |
| 2017 | $143.43 | $147.95 | 0.0% | +3.2% | |
| 2016 | $156.61 | $143.43 | 0.0% | -8.4% | |
| 2015 | $129.49 | $156.61 | 0.0% | +20.9% | |
| 2014 | $113.08 | $129.49 | 0.0% | +14.5% | |
| 2013 | $53.42 | $113.08 | 0.0% | +111.7% | |
| 2012 | $47.25 | $53.42 | 0.0% | +13.1% | |
| 2011 | $63.22 | $47.25 | 0.0% | -25.3% | |
| 2010 | $52.65 | $63.22 | 0.0% | +20.1% | |
| 2009 | $31.28 | $52.65 | 0.0% | +68.3% | |
| 2008 | $48.83 | $31.28 | 0.0% | -35.9% | |
| 2007 | $27.19 | $48.83 | 0.0% | +79.6% | |
| 2006 | $34.56 | $27.19 | 0.0% | -21.3% | |
| 2005 | $22.58 | $34.56 | 0.0% | +53.1% | |
| 2004 | $11.48 | $22.58 | 0.0% | +96.7% | |
| 2003 | $8.35 | $11.48 | 0.0% | +37.4% | |
| 2002 | $5.21 | $8.35 | 0.0% | +60.4% | |
| 2001 | $7.38 | $5.21 | 0.0% | -29.4% | |
| 2000 | $23.00 | $7.38 | 0.0% | -67.9% |
- Annualized
- +18.0%
- 2000–2026
- Average year
- +21.8%
- 26 full years
- Best year
- +111.7%
- 2013
- Worst year
- -67.9%
- 2000
- Positive years
- 17/26
- 65% up
Annualized (CAGR)
+18.0%
2000–2026
Average year
+21.8%
26 full years
Best year
+111.7%
2013
Worst year
-67.9%
2000
Positive years
17/26
65% up
Total return by period#
Annual
-100%-50%0%50%100%
2000-68%'00
2001-29%
2002+60%'02
2003+37%
2004+97%'04
2005+53%
2006-21%'06
2007+80%
2008-36%'08
2009+68%
2010+20%'10
2011-25%
2012+13%'12
2013+112%
2014+15%'14
2015+21%
2016-8.4%'16
2017+3.2%
2018-26%'18
2019-19%
2020+72%'20
2021+42%
2022+29%'22
2023-21%
2024+60%'24
2025+38%
2026+11%'26
Methodology#
Total returns, dividends reinvested, measured on UTHR. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is United Therapeutics Corporation's average annual return?
- Since 2000, United Therapeutics Corporation (UTHR) has returned about 18.0% a year (the compound annual growth rate) and an average calendar-year return of 21.8%.
- What were United Therapeutics Corporation's best and worst years?
- Over 2000–2026, the best year was 2013 (+111.7%) and the worst was 2000 (-67.9%).
- How often is United Therapeutics Corporation up in a year?
- 17 of the 26 full years since 2000 were positive — about 65% of the time.
More on United Therapeutics Corporation
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100